top of page

Meet NewBiologix, an innovative Swiss biotech company dedicated to revolutionizing the field of gene therapy

  • blonca9
  • May 16
  • 1 min read

At #ASGCT2025, we met up with Founder and CEO Igor Fisch, who described the pillars that make NewBiologix a partner of choice in the rAAV field.



Key pillars:


I. Its proprietary Xcell™ Eng-HEK293 Cell Line.

II. Production of rAAV samples that are of the highest purity and quality.

III. Analytics that ensure clients receive the highest quality data and insights.


He also describes how NewBiologix will offer a new platform that allows for the production of viral particles with a stable cell line so that triple transfection isn't needed, thus lowering the cost of goods significantly.




Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

evaluate-logo-png_seeklogo-457165-2_edited.png

Evaluate is a trusted provider of forecasting and commercial intelligence to the pharmaceutical industry. With a combination of gold standard data sources and deep pharma expertise, Evaluate helps clients make the right portfolio decisions to drive growth.

​

​Evaluate's solutions provide a complete, dynamic view of development risk and commercial return across the full clinical lifecycle, underpinned by consensus forecasts to 2032, pipelines, deals and more. A consulting and analytics team is on always hand to help clients address unique clinical and commercial challenges.

Learn more about Evaluate

bottom of page